Skip to main content
. 2015 May 5;100(7):2557–2564. doi: 10.1210/jc.2015-1606

Figure 5. Inhibition of E2F1 interaction with POMC regulatory sequences by R-roscovitine in corticotroph tumors.

Figure 5.

ChIP assays were performed in AtT20 cells treated with vehicle (Ros−) or R-roscovitine (Ros+) using PCR primer sets corresponding to the enhancer (ChIP1), the distal (ChIP2), and proximal (ChIP3) promoter region (A) with anti-E2F1 (E2F1) (B), antiacetyl histone H4 (AcH4) (C) antibodies, or negative control (IgG).